Author

H. K. Voges

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cell Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:human· 2 Assay:bulk RNA-seq· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:cell type annotation· 1 Research Focus:drug response / drug discovery· 1 Organism:mouse· 1 Assay:scRNA-seq· 1

Frequent Co-Authors

D. A. Elliott· 2 shared E. R. Porrello· 2 shared K. Karavendzas· 2 shared R. J. Mills· 2 shared A. Suhrbier· 1 shared B. Griffen· 1 shared B. L. Parker· 1 shared B. W. C. Tse· 1 shared

Activity by Year

2020-2022 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 40 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCell Biology

D. A. Elliott

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Alpha kinase 3 signaling at the M-band maintains sarcomere integrity and proteostasis in striated muscle.

J. W. McNamara, B. L. Parker, H. K. Voges, N. R. R. Mehdiabadi, F. Bolk, D. D. Chung, N. Charitakis, J. Molendijk, S. Lal, M. Ramialison, K. Karavendzas, H. L. Pointer, P. Syrris, L. R. Lopes, E. M. Perry, , D. A. Elliott

This study identifies ALPK3's role in maintaining sarcomere integrity and proteostasis in striated muscle by localizing to the M-band and interacting with SQSTM1.

bioRxiv · Sep 1, 2022Cell Biology

Bromodomain and Extraterminal Inhibition Blocks Inflammation-Induced Cardiac Dysfunction and SARS-CoV-2 Infection (Pre-Clinical)

R. J. Mills, S. J. Humphrey, P. R. Fortuna, M. Lor, S. R. Foster, G. A. Quaife-Ryan, R. L. Johnston, T. Dumenil, C. Bishop, R. Ruraraju, D. J. Rawle, T. Le, W. Zhao, L. Lee, C. Mackenzie-Kludas, , E

The paper identifies BET inhibitors as potential cardio-protective drugs that block inflammation-induced cardiac dysfunction and SARS-CoV-2 infection in pre-clinical models.

bioRxiv · Aug 23, 2020 · PreprintCell Biology